Donna R Rivera (Donna Rivera)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 32

Top Topics

Electronic Health Record

Metastatic Breast Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JCO clinical cancer informatics

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Elizabeth S Duke, Diana Bradford, Arup K Sinha, Pallavi S Mishra-Kalyani, Catherine C Lerro, Donna R Rivera, Emily Wearne, Claudia P Miller, John Leighton, Hairat Sabit, Hong Zhao, Ashley Lane, Barbara Scepura, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Nicole Drezner
FDA Approval Summary: Eflornithine for High-Risk Neuroblastoma Following Prior Multiagent, Multimodality Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Catherine C Lerro, Marie C Bradley, Richard A Forshee, Donna R Rivera
The Bar Is High: Evaluating Fit-for-Use Oncology Real-World Data for Regulatory Decision Making. JCO clinical cancer informatics 8 (2024)
Elizabeth S Duke, Diana Bradford, Arup K Sinha, Pallavi S Mishra-Kalyani, Catherine C Lerro, Donna R Rivera, Emily Wearne, Claudia P Miller, John Leighton, Hairat Sabit, Hong Zhao, Ashley Lane, Barbara Scepura, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Nicole Drezner
US Food and Drug Administration Approval Summary: Eflornithine for High-Risk Neuroblastoma After Prior Multiagent, Multimodality Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Elizabeth S Duke, Diana Bradford, Arup K Sinha, Pallavi S Mishra-Kalyani, Catherine C Lerro, Donna R Rivera, Emily Wearne, Claudia P Miller, John Leighton, Hairat Sabit, Hong Zhao, Ashley Lane, Barbara Scepura, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Nicole Drezner
US Food and Drug Administration Approval Summary: Eflornithine for High-Risk Neuroblastoma After Prior Multiagent, Multimodality Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Ashley S Margol, Annette M Molinaro, Arzu Onar-Thomas, Adam Resnick, Derek Hanson, Mark Kieran, Pallavi Mishra-Kalyani, Donna R Rivera, Amy Barone, David Arons, Clair Meehan, Michael D Prados
Use of External Control Cohorts in Pediatric Brain Tumor Clinical Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Brittany Avin McKelvey, Elizabeth Garrett-Mayer, Donna R Rivera, Amy Alabaster, Hillary S Andrews, Elizabeth G Bond, Thomas D Brown, Amanda Bruno, Lauren Damato, Janet L Espirito, Laura L Fernandes, Eric Hansen, Paul Kluetz, Xinran Ma, Andrea McCracken, Pallavi S Mishra-Kalyani, Yanina Natanzon, Danielle Potter, Nicholas J Robert, Lawrence Schwartz, Regina Schwind, Connor Sweetnam, Joseph Wagner, Mark D Stewart, Jeff D Allen
Evaluation of Real-World Tumor Response Derived From Electronic Health Record Data Sources: A Feasibility Analysis in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Chemotherapy. JCO clinical cancer informatics 8 (2024)
Jenna Bhimani, Kelli O'Connell, Isaac J Ergas, Marilyn Foley, Grace B Gallagher, Jennifer J Griggs, Narre Heon, Tatjana Kolevska, Yuriy Kotsurovskyy, Candyce H Kroenke, Cecile A Laurent, Raymond Liu, Kanichi G Nakata, Sonia Persaud, Donna R Rivera, Janise M Roh, Sara M Tabatabai, Emily Valice, Erin J Aiello Bowles, Elisa V Bandera, Lawrence H Kushi, Elizabeth D Kantor
Methodology for Using Real-World Data From Electronic Health Records to Assess Chemotherapy Administration in Women With Breast Cancer. JCO clinical cancer informatics 8 (2024)
Jenna Bhimani, Kelli O'Connell, Sonia Persaud, Victoria S Blinder, Rachael P Burganowski-Doud, Isaac J Ergas, Grace B Gallagher, Jennifer J Griggs, Narre Heon, Tatjana Kolevska, Yuriy Kotsurovskyy, Candyce H Kroenke, Cecile A Laurent, Raymond Liu, Kanichi G Nakata, Donna R Rivera, Janise M Roh, Sara M Tabatabai, Emily Valice, Elisa V Bandera, Erin J Aiello Bowles, Lawrence H Kushi, Elizabeth D Kantor
Patient characteristics associated with intended non-guideline chemotherapy in women with stage I-IIIA breast cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2024)
Elizabeth S Duke, Diana Bradford, Arup K Sinha, Pallavi S Mishra-Kalyani, Catherine C Lerro, Donna R Rivera, Emily Wearne, Claudia P Miller, John Leighton, Hairat Sabit, Hong Zhao, Ashley Lane, Barbara Scepura, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Nicole Drezner
US Food and Drug Administration Approval Summary: Eflornithine for High-Risk Neuroblastoma After Prior Multiagent, Multimodality Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Ashley S Margol, Annette M Molinaro, Arzu Onar-Thomas, Adam Resnick, Derek Hanson, Mark Kieran, Pallavi Mishra-Kalyani, Donna R Rivera, Amy Barone, David Arons, Clair Meehan, Michael D Prados
Use of External Control Cohorts in Pediatric Brain Tumor Clinical Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Elizabeth S Duke, Diana Bradford, Arup K Sinha, Pallavi S Mishra-Kalyani, Catherine C Lerro, Donna R Rivera, Emily Wearne, Claudia P Miller, John Leighton, Hairat Sabit, Hong Zhao, Ashley Lane, Barbara Scepura, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Nicole Drezner
US Food and Drug Administration Approval Summary: Eflornithine for High-Risk Neuroblastoma After Prior Multiagent, Multimodality Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Jenna Bhimani, Kelli O'Connell, Sonia Persaud, Victoria S Blinder, Rachael P Burganowski-Doud, Isaac J Ergas, Grace B Gallagher, Jennifer J Griggs, Narre Heon, Tatjana Kolevska, Yuriy Kotsurovskyy, Candyce H Kroenke, Cecile A Laurent, Raymond Liu, Kanichi G Nakata, Donna R Rivera, Janise M Roh, Sara M Tabatabai, Emily Valice, Elisa V Bandera, Erin J Aiello Bowles, Lawrence H Kushi, Elizabeth D Kantor
Patient characteristics associated with intended non-guideline chemotherapy in women with stage I-IIIA breast cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2024)
Elizabeth S Duke, Diana Bradford, Arup K Sinha, Pallavi S Mishra-Kalyani, Catherine C Lerro, Donna R Rivera, Emily Wearne, Claudia P Miller, John Leighton, Hairat Sabit, Hong Zhao, Ashley Lane, Barbara Scepura, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Nicole Drezner
US Food and Drug Administration Approval Summary: Eflornithine for High-Risk Neuroblastoma After Prior Multiagent, Multimodality Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Elizabeth S Duke, Diana Bradford, Arup K Sinha, Pallavi S Mishra-Kalyani, Catherine C Lerro, Donna R Rivera, Emily Wearne, Claudia P Miller, John Leighton, Hairat Sabit, Hong Zhao, Ashley Lane, Barbara Scepura, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Nicole Drezner
FDA Approval Summary: Eflornithine for High-Risk Neuroblastoma Following Prior Multiagent, Multimodality Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Catherine C Lerro, Marie C Bradley, Richard A Forshee, Donna R Rivera
The Bar Is High: Evaluating Fit-for-Use Oncology Real-World Data for Regulatory Decision Making. JCO clinical cancer informatics 8 (2024)
Ashley S Margol, Annette M Molinaro, Arzu Onar-Thomas, Adam Resnick, Derek Hanson, Mark Kieran, Pallavi Mishra-Kalyani, Donna R Rivera, Amy Barone, David Arons, Clair Meehan, Michael D Prados
Use of External Control Cohorts in Pediatric Brain Tumor Clinical Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Catherine C Lerro, Marie C Bradley, Richard A Forshee, Donna R Rivera
The Bar Is High: Evaluating Fit-for-Use Oncology Real-World Data for Regulatory Decision Making. JCO clinical cancer informatics 8 (2024)
Elizabeth S Duke, Diana Bradford, Arup K Sinha, Pallavi S Mishra-Kalyani, Catherine C Lerro, Donna R Rivera, Emily Wearne, Claudia P Miller, John Leighton, Hairat Sabit, Hong Zhao, Ashley Lane, Barbara Scepura, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Nicole Drezner
FDA Approval Summary: Eflornithine for High-Risk Neuroblastoma Following Prior Multiagent, Multimodality Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Jennifer J Gao, Christy L Osgood, Zhou Feng, Erik W Bloomquist, Shenghui Tang, C J George Chang, Tiffany K Ricks, Sherry C Hou, William F Pierce, Donna R Rivera, Richard Pazdur, Paul G Kluetz, Laleh Amiri-Kordestani
FDA Approval Summary: Ribociclib Indicated for Male Patients with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Sonia Singh, Diana Bradford, Xiaoxue Li, Pallavi S Mishra-Kalyani, Yuan Li Shen, Lingshan Wang, Hong Zhao, Ye Xiong, Jiang Liu, Rosane Charlab, Jeffrey Kraft, Sachia Khasar, Claudia P Miller, Donna R Rivera, Paul G Kluetz, Richard Pazdur, Julia A Beaver, Harpreet Singh, Martha Donoghue
FDA Approval Summary: Alpelisib for PIK3CA-related Overgrowth Spectrum (PROS). Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Qi Liu, Chenan Zhang, Yue Huang, Ruihao Huang, Shiew Mei Huang, Erin Larkins, Liza Stapleford, Donna R Rivera, Paul G Kluetz, Shenggang Wang, Hao Zhu, James L Weese, Elizabeth Cromartie, Mahder Teka, Sheetal Walters, Frank M Wolf, Thomas D Brown
Evaluating Pneumonitis Incidence in Patients with Non-small Cell Lung Cancer Treated with Immunotherapy and/or Chemotherapy Using Real-world and Clinical Trial Data. Cancer research communications 3 (2) (2023)
Qi Liu, Chenan Zhang, Yue Huang, Ruihao Huang, Shiew Mei Huang, Erin Larkins, Liza Stapleford, Donna R Rivera, Paul G Kluetz, Shenggang Wang, Hao Zhu, James L Weese, Elizabeth Cromartie, Mahder Teka, Sheetal Walters, Frank M Wolf, Thomas D Brown
Evaluating Pneumonitis Incidence in Patients with Non-small Cell Lung Cancer Treated with Immunotherapy and/or Chemotherapy Using Real-world and Clinical Trial Data. Cancer research communications 3 (2) (2023)
Mary E Charlton, Amanda R Kahl, Bradley D McDowell, Robert S Miller, George A Komatsoulis, Jacob E Koskimaki, Donna R Rivera, Kathleen A Cronin
Cancer Registry Data Linkage of Electronic Health Record Data From ASCO's CancerLinQ: Evaluation of Advantages, Limitations, and Lessons Learned. JCO clinical cancer informatics 6 (2022)
Julie A Schneider, Yutao Gong, Kirsten B Goldberg, Paul G Kluetz, Marc R Theoret, Laleh Amiri-Kordestani, Julia A Beaver, Lola A Fashoyin-Aje, Nicole J Gormley, Adnan A Jaigirdar, Steven J Lemery, Pallavi S Mishra-Kalyani, Gregory H Reaman, Donna R Rivera, Wendy S Rubinstein, Harpreet Singh, Rajeshwari Sridhara, Richard Pazdur
The FDA Oncology Center of Excellence Scientific Collaborative: Charting a Course for Applied Regulatory Science Research in Oncology. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Elena Roel, Andrea Pistillo, Martina Recalde, Anthony G Sena, Sergio Fernández-Bertolín, Maria Aragón, Diana Puente, Waheed-Ul-Rahman Ahmed, Hiba Alghoul, Osaid H Alser, Thamir M Alshammari, Carlos Morgado Areia, Clair Blacketer, William Carter, Paula Casajust, Aedin C Culhane, Dalia M Dawoud, Frank DeFalco, Scott L Duvall, Thomas Falconer, Asieh Golozar, Mengchun Gong, Laura L Hester, George Hripcsak, Eng Hooi Tan, Hokyun Jeon, Jitendra Jonnagaddala, Lana Y H Lai, Kristine E Lynch, Michael E Matheny, Daniel R Morales, Karthik Natarajan, Fredrik Nyberg, Anna Ostropolets, José D Posada, Albert Prats-Uribe, Christian G Reich, Donna R Rivera, Lisa M Schilling, Isabelle Soerjomataram, Karishma Shah, Nigam Haresh Shah, Yang Shen, Matthew Spotniz, Vignesh Subbian, Marc A Suchard, Annalisa Trama, Lin Zhang, Ying Zhang, Patrick B Ryan, Daniel Prieto-Alhambra, Kristin Kostka, Talita Duarte Salles
Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and Spain. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 30 (10) (2021)
Arielle Elkrief, Julie Tsu-Yu Wu, Chinmay T Jani, Kyle T Enriquez, Michael Glover, Mansi R Shah, Hira Ghazal Shaikh, Alicia Beeghly-Fadiel, Benjamin French, Sachin M Jhawar, Douglas B Johnson, Rana R McKay, Donna R Rivera, Daniel Y Reuben, Surbhi Shah, Stacey L Tinianov, Donald Cuong Vinh, Sanjay Mishra, Jeremy L Warner
Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer. Cancer discovery (2021)
Andrew E Grothen, Bethany Tennant, Catherine Wang, Andrea Torres, Bonny Bloodgood Sheppard, Glenn Abastillas, Marina Matatova, Jeremy L Warner, Donna R Rivera
Application of Artificial Intelligence Methods to Pharmacy Data for Cancer Surveillance and Epidemiology Research: A Systematic Review. JCO clinical cancer informatics 4 (2021)
William A Wood, Peter W Marks, Robert M Plovnick, Kathleen Hewitt, Donna Neuberg, Sam Walters, Brendan K Dolan, Emily Tucker, Charles S Abrams, Alexis A Thompson, Kenneth C Anderson, Paul Kluetz, Ann T Farrell, Donna R Rivera, Matthew Gertzog, Gregory Pappas
ASH Research Collaborative: A Real-World Data Infrastructure to Support Real-World Evidence Development and Learning Healthcare Systems in Hematology. Blood advances (2021)
Lynne T Penberthy, Donna R Rivera, Jennifer L Lund, Melissa A Bruno, Anne-Marie Meyer
An overview of real-world data sources for oncology and considerations for research. CA: a cancer journal for clinicians 72 (3) (2021)
Monica E D'Arcy, Daniel C Beachler, Ruth M Pfeiffer, Jeffrey R Curtis, Xavier Mariette, Raphaele Seror, Parag S Mahale, Donna R Rivera, Elizabeth L Yanik, Eric A Engels
Tumor Necrosis Factor Inhibitors and the Risk of Cancer among Older Americans with Rheumatoid Arthritis. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 30 (11) (2021)
Donna R Rivera, Mugdha N Gokhale, Matthew W Reynolds, Elizabeth B Andrews, Danielle S Chun, Kevin Haynes, Michele L Jonsson-Funk, Kristine E Lynch, Jennifer L Lund, Helen Strongman, Harshvinder Bhullar, Sudha R Raman
Linking electronic health data in pharmacoepidemiology: Appropriateness and feasibility. Pharmacoepidemiology and drug safety 29 (1) (2020)
Donna R Rivera, Solange Peters, Orestis A Panagiotou, Dimpy P Shah, Nicole M Kuderer, Chih-Yuan Hsu, Samuel M Rubinstein, Brendan J Lee, Toni K Choueiri, Gilberto de Lima Lopes, Petros D Grivas, Corrie A Painter, Brian I Rini, Michael A Thompson, Jonathan Arcobello, Ziad Bakouny, Deborah B Doroshow, Pamela C Egan, Dimitrios Farmakiotis, Leslie A Fecher, Christopher R Friese, Matthew D Galsky, Sanjay Goel, Shilpa Gupta, Thorvardur R Halfdanarson, Balazs Halmos, Jessica E Hawley, Ali Raza Khaki, Christopher A Lemmon, Sanjay Mishra, Adam J Olszewski, Nathan A Pennell, Matthew M Puc, Sanjay G Revankar, Lidia Schapira, Andrew Schmidt, Gary K Schwartz, Sumit A Shah, Julie Tsu-Yu Wu, Zhuoer Xie, Albert C Yeh, Huili Zhu, Yu Shyr, Gary H Lyman, Jeremy L Warner, null null
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study. Cancer discovery 10 (10) (2020)